CRISPRi/a screens in human iPSC-cardiomyocytes identify glycolytic activation as a druggable target for doxorubicin-induced cardiotoxicity
- Chun Liu
- , Mengcheng Shen
- , Yanxia Liu
- , Amit Manhas
- , Shane Rui Zhao
- , Mao Zhang
- , Nadjet Belbachir
- , Lu Ren
- , Joe Z. Zhang
- , Arianne Caudal
- , Masataka Nishiga
- , Dilip Thomas
- , Angela Zhang
- , Huaxiao Yang
- , Yang Zhou
- , Mohamed Ameen
- , Nazish Sayed
- , June Wha Rhee
- , Lei S. Qi
- , Joseph C. Wu
- Division of Cardiology
- Roy and Diana Vagelos Division of Biology & Biomedical Sciences (DBBS)
- DBBS - Developmental, Regenerative and Stem Cell Biology
- DBBS - Immunology
- DBBS - Molecular Cell Biology
- DBBS - Molecular Genetics and Genomics
- DBBS - Neurosciences
- Center of Regenerative Medicine
- Siteman Cancer Center
- Institute of Clinical and Translational Sciences (ICTS)
- Center for Cardiovascular Research
Research output: Contribution to journal › Article › peer-review
28
Link opens in a new tab
Scopus
citations